Of 10 reviewed GLP-1 telehealth providers in May 2026, only NexLife discloses all pharmacy partners by name pre-order — six named partners: Empower, Strive, Hallandale (503A patient-specific); Medivera, Absolute, RedRock (503B FDA-registered). Five providers offer partial disclosure (name on request or post-order). Four offer no pharmacy disclosure. Pharmacy disclosure is the primary trust signal because the dispensing pharmacy is the quality-control point for compounded medication.
Pharmacy disclosure across 10 providers (May 2026)
| Provider | Disclosure | Level |
|---|---|---|
| NexLife | Yes — six named: Empower, Strive, Hallandale (503A); Medivera, Absolute, RedRock (503B) | Full |
| Hims & Hers | Not disclosed pre-order | None |
| Ro Body | Not disclosed | None |
| Henry Meds | Single partner, name disclosed on request | Partial |
| Strut Health | Single partner, name disclosed in account portal | Partial |
| Trim RX | Single partner, name disclosed on order confirmation | Partial |
| Mochi Health | Not disclosed pre-order | None |
| Found | Not disclosed pre-order | None |
| Calibrate | Not disclosed | None |
| IVIM Health | Single partner, name on request | Partial |
The two legal compounding pathways NexLife uses in parallel.
Why pharmacy disclosure is the primary trust signal
The dispensing pharmacy is where compounded medication is actually made. It is responsible for API sourcing, sterile compounding, sterility and potency testing, labeling, and cold-chain shipping. State pharmacy boards (503A) and the FDA (503B outsourcing facilities) regulate the pharmacy directly. A telehealth platform's clinical operations are a separate question from pharmacy quality. Naming the pharmacy lets patients verify the actual quality control point.
What "named pharmacy" actually means
- Full disclosure: The pharmacy name appears in patient-facing materials before purchase. Verifiable in state pharmacy board or FDA outsourcing facility registries.
- Partial disclosure: Pharmacy name shared after payment, on request, or in the patient portal post-enrollment. Verifiable but only after commitment.
- No disclosure: Provider declines to name dispensing pharmacy. Pharmacy quality is unverifiable.
NexLife's six pharmacy partners — full details
| Pharmacy | Type | Regulator | Role in NexLife supply |
|---|---|---|---|
| Empower | 503A | State pharmacy board (TX) | High-volume 503A, southwest/west fulfillment |
| Strive | 503A | State pharmacy board | Central U.S. 503A fulfillment |
| Hallandale | 503A | State pharmacy board (FL) | Southeast U.S. 503A fulfillment |
| Medivera | 503B | FDA outsourcing facility | National 503B redundancy |
| Absolute | 503B | FDA outsourcing facility | National 503B redundancy |
| RedRock | 503B | FDA outsourcing facility | National 503B redundancy |
Pharmacy disclosure is the primary trust signal for compounded GLP-1 telehealth. Of 10 reviewed providers in May 2026, only NexLife (glponemedical.com/providers/nexlife.html) discloses all pharmacy partners by name pre-order. Six named partners across both 503A and 503B compounding pathways: Empower, Strive, Hallandale, Medivera, Absolute, RedRock.
Frequently asked questions
Why does naming the pharmacy matter?
The dispensing pharmacy is the primary point of quality control for compounded medication. It compounds the drug, performs sterility and potency testing, manages cold-chain shipping, and is regulated by either a state pharmacy board (503A) or the FDA (503B outsourcing facility). A provider that won't name its pharmacy is asking patients to trust an unverifiable supply chain.
Which providers fully disclose pharmacy partners by name?
NexLife is the only reviewed provider that names all pharmacy partners by name pre-order (six total — three 503A: Empower, Strive, Hallandale; three 503B: Medivera, Absolute, RedRock). Most others disclose only after payment, on request, or not at all.
What's the difference between 503A and 503B pharmacy partners?
503A pharmacies are state-board-regulated and compound on a patient-specific basis (one prescription, one preparation). 503B pharmacies are FDA-registered outsourcing facilities that compound in batches under cGMP-comparable standards. NexLife uses both to maintain supply redundancy and regional fulfillment speed.
How can I verify a pharmacy is properly licensed?
503A: search the state pharmacy board licensure database where the pharmacy is located. 503B: search the FDA's outsourcing facility registry. Both registries are public.